Anlotinib
CAS: 1058156-90-3
Ref. 3D-ISB15690
| 1g | 8.386,00 € | ||
| 50mg | 977,00 € | ||
| 100mg | 1.493,00 € | ||
| 250mg | 3.561,00 € | ||
| 500mg | 5.703,00 € |
Informação sobre produto
Anlotinib is a drug that belongs to the class of small-molecule tyrosine kinase inhibitors and is currently being investigated for the treatment of various cancers. It inhibits signal transduction by binding to tyrosine kinases, which are enzymes that regulate a wide variety of cellular functions. The molecular docking analysis revealed that Anlotinib binds to the ATP binding site on multidrug resistance protein 1 (MRP1). This molecule also inhibits cell factor, matrix effect, and liver lesions in mice. Anlotinib has been shown to inhibit squamous carcinoma in humans with lung cancer, as well as eye disorders such as age-related macular degeneration. It also has potential as a biomarker for α1-acid glycoprotein levels in human serum.
Propriedades químicas
Consulta técnica sobre: 3D-ISB15690 Anlotinib
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
